Want to see HBIO full AI Analyst Report?
Harvard Bioscience (HBIO) Ownership - Who Owns Harvard Bioscience?
Harvard Bioscience (HBIO) Ownership Overview
- 9.39% Insiders
- 20.06% Mutual Funds
- 6.60% Other Institutional Investors
- 3.81% ETFs
- 60.15% Public Companies and Individual Investors
The ownership structure of Harvard Bioscience (HBIO) stock is a mix of institutional, retail, and individual investors. Approximately 30.46% of the company’s stock is owned by Institutional Investors, 9.39% is owned by Insiders, and 60.15% is owned by Public Companies and Individual Investors.
The ownership structure of Harvard Bioscience (HBIO) stock is a mix of institutional, retail, and individual investors. Approximately 30.46% of the company’s stock is owned by Institutional Investors, 9.39% is owned by Insiders, and 60.15% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Mar 31, 2026 | Mark Frost | $25,000 | |
| Mar 17, 2026 | William Snider | $103,604 | |
| Mar 17, 2026 | Stephen J Denelsky | $48,700 | |
| Mar 16, 2026 | John D Duke | $25,050 |
Recent Hedge Fund Trading Activity
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Rutland Square Trust Ii | 344,113 | Institution | 7.56% | 3,062,606 |
| John D Duke | 180,000 | Insider | 3.95% | 1,602,000 |
| Vanguard | 167,953 | Institution | 3.69% | 1,494,782 |
| Vanguard Index Funds | 165,513 | Institution | 3.64% | 1,473,066 |
| Royce Fund | 121,940 | Institution | 2.68% | 1,085,266 |
| Tiaa-cref Funds | 119,971 | Institution | 2.64% | 1,067,742 |
| Katherine A. Eade | 58,669 | Insider | 1.29% | 522,154 |
| Northern Funds | 58,250 | Institution | 1.28% | 518,425 |
| Mario Gabelli | 57,000 | Institution | 1.25% | 507,300 |
| William Snider | 48,556 | Insider | 1.07% | 432,148 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Rutland Square Trust Ii | 344,113 | Institution | 7.56% | 3,062,606 |
| Vanguard Index Funds | 165,513 | Institution | 3.64% | 1,473,066 |
| Royce Fund | 121,940 | Institution | 2.68% | 1,085,266 |
| Tiaa-cref Funds | 119,971 | Institution | 2.64% | 1,067,742 |
| Northern Funds | 58,250 | Institution | 1.28% | 518,425 |
| Destra Investment Trust | 37,219 | Institution | 0.82% | 331,249 |
| Fidelity Concord Street Trust | 36,935 | Institution | 0.81% | 328,722 |
| Forum Funds Ii | 13,380 | Institution | 0.29% | 119,082 |
| Vanguard Valley Forge Funds | 4,112 | Institution | 0.09% | 36,597 |
| Victory Portfolios Iii | 4,107 | Institution | 0.09% | 36,552 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VTI ETF | 123,470 | Institution | 2.71% | 977,882 |
| Vanguard, VXF ETF | 44,483 | Institution | 0.98% | 352,305 |
| -, DWMC ETF | 2,044 | Institution | 0.04% | 8,462 |
| Dimensional, DFSU ETF | 1,902 | Institution | 0.04% | 16,738 |
| DFA, DFAS ETF | 1,624 | Institution | 0.04% | 14,291 |
| DFA, DFAC ETF | 1,029 | Institution | 0.02% | 9,055 |
| DFA, DCOR ETF | 928 | Institution | 0.02% | 8,166 |
FAQ
Who Owns Harvard Bioscience (HBIO)?
According to the latest TipRanks data, approximately 30.46% of the company's stock is held by institutional investors, 9.39% is held by insiders, and 60.15% is held by public companies and individual investors.
What percentage of Harvard Bioscience (HBIO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 30.46% of Harvard Bioscience (HBIO) stock is held by institutional investors: 20.06% by mutual funds, 3.81% by ETFs and 6.60% by other institutional investors.
What percentage of Harvard Bioscience (HBIO) stock is held by retail investors?
According to the latest TipRanks data, approximately 60.15% of Harvard Bioscience (HBIO) stock is held by public companies and individual investors.
Who owns the most shares of Harvard Bioscience (HBIO)?
Fidelity Rutland Square Trust II owns the most shares of Harvard Bioscience (HBIO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.